US Aspiration and Biopsy Needle Market Insight
Published: 10 June 2026 | Report Format: Electronic (PDF)
The United States Aspiration and Biopsy Needle Market is projected to grow at a CAGR of around 7.8%, driven by increasing cancer prevalence, rising demand for minimally invasive diagnostic procedures, expanding image-guided biopsy adoption, and advancements in precision needle technologies.
United States Aspiration and Biopsy Needle Market Forecasts to 2035
- The United States Aspiration and Biopsy Needle Market Size Was Estimated at USD 1.42 Billion in 2025.
- The Market Size is Expected to Grow at a CAGR of around 7.8% from 2025 to 2035
- The United States Aspiration and Biopsy Needle Market Size is Expected to Reach around USD 3.01 Billion by 2035.
Notable Insights for the United States Aspiration and Biopsy Needle Market
- Segmentation Based on Product Type, Fine Needle Aspiration (FNA) Needles, Core Biopsy Needles, and Vacuum-Assisted Biopsy Needles segments held a dominant position in the United States Aspiration and Biopsy Needle Market in 2025 with nearly 79% share, driven by increasing utilization in cancer diagnostics and tissue sampling procedures.
- Segmentation Based on Application, Breast Biopsy, Lung Biopsy, and Prostate Biopsy collectively accounted for approximately 74% share in 2025, supported by rising screening programs, growing oncology caseloads, and expanding use of image-guided interventions.
- The United States Aspiration and Biopsy Needle Market is led by BD, Hologic Inc., and Cook Medical, with combined revenues exceeding USD 27.8 Billion in 2025, reflecting strong diagnostic portfolios, broad healthcare distribution networks, and continued investments in minimally invasive biopsy technologies.
- Rising adoption of ultrasound-guided biopsies, robotic-assisted interventions, precision sampling technologies, and advanced imaging integration is projected to improve diagnostic accuracy by nearly 24% while reducing repeat biopsy procedures by approximately 19% during the forecast period.
Download the eBook (ToC)
Why Buy This Report
- Provides a comprehensive analysis of the impact of cancer incidence trends, minimally invasive diagnostic procedures, healthcare infrastructure development, reimbursement policies, and technological advancements on market growth.
- Offers key insights into technological advancements in image-guided biopsy systems, vacuum-assisted tissue sampling, robotic intervention platforms, precision needle design, and integrated diagnostic workflows.
- Helps stakeholders evaluate competitive positioning, product innovation strategies, regulatory developments, hospital procurement trends, healthcare provider preferences, and growth opportunities across the aspiration and biopsy needle ecosystem.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United States aspiration and biopsy needle market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States Aspiration and Biopsy Needle Market
• Becton, Dickinson and Company (BD)
• Hologic Inc.
• Cook Medical
• Argon Medical Devices, Inc.
• Cardinal Health, Inc.
• Boston Scientific Corporation
• Merit Medical Systems, Inc.
• CONMED Corporation
• Medtronic plc
• Olympus Corporation
Recent Developments:
- In October 2025, Hologic Inc. launched an advanced vacuum-assisted breast biopsy solution featuring enhanced tissue acquisition capabilities and workflow optimization designed for outpatient diagnostic centers and hospitals.
- In June 2025, BD collaborated with GE HealthCare to improve image-guided biopsy workflows through integrated diagnostic solutions, supporting greater procedural accuracy and efficiency across interventional radiology settings.
Market Segmentation:
United States Aspiration and Biopsy Needle Market, By Product Type
• Fine Needle Aspiration (FNA) Needles
• Core Biopsy Needles
• Vacuum-Assisted Biopsy Needles
• Bone Marrow Biopsy Needles
• Specialty Biopsy Needles
United States Aspiration and Biopsy Needle Market, By Application
• Breast Biopsy
• Lung Biopsy
• Prostate Biopsy
• Liver Biopsy
• Bone Marrow Biopsy
• Others
United States Aspiration and Biopsy Needle Market, By Procedure Guidance
• Ultrasound-Guided Biopsy
• CT-Guided Biopsy
• MRI-Guided Biopsy
• Stereotactic-Guided Biopsy
United States Aspiration and Biopsy Needle Market, By End User
• Hospitals
• Diagnostic Imaging Centers
• Ambulatory Surgical Centers
• Specialty Clinics
United States Aspiration and Biopsy Needle Market, By Distribution Channel
• Direct Sales
• Medical Device Distributors
• Group Purchasing Organizations (GPOs)
• Online Procurement Platforms
Expert Views:
The United States Aspiration and Biopsy Needle Market is expected to witness steady growth through 2035, supported by increasing cancer screening initiatives, rising demand for minimally invasive diagnostics, and continuous advancements in image-guided intervention technologies. Innovations in precision biopsy systems, robotic-assisted procedures, and integrated diagnostic platforms are anticipated to strengthen clinical outcomes and procedural efficiency. As healthcare providers continue prioritizing early disease detection and accurate tissue diagnosis, the market will remain a critical component of the United States medical device and diagnostic healthcare industry.
Author: Govind and Krishna By Spherical Insights and Consulting